References
- Kawaguchi A, Goldman M H., Shapiro R., Foegh M I., Ramwell P W., Lower R R. Increase in urinary thromboxane B, in rats caused by cyclosporine. Transplantation 1985; 40: 214–216
- Grace A A., Barradas M A., Mikhailidis D P., et al. Cyclosporine A enhances platelet aggregation. Kidney Int 1987; 32: 889–895
- Neild G H., Rocchi G, Imberti I, et al. Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 1983; 32: 373–379
- Siekierka J J., Sigal N H. FK 506 and cyclosporine A: immunosuppressive mechanism of action and beyond. Curr Opin Immunol 1992; 4: 548–552
- Peters D H., Fitton A, Plosker G L., Faulds D. Tacrolimus: a review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993; 46: 746–794
- Tanaka H, Kuroda A, Marusawa H. Structure of FK 506: a novel immunosuppressant isolated from Streptomyces. J 1987; 109: 5031–5033
- Petcher T J., Weber H P., Ruegger A. Crystal and molecular structure of an iododerivative of the cyclic undecapeptide cyclosporin A. Helv Chim Acta 1976; 59: 1480–1484
- Wilsoncroft P S., Lofts F J., Griffits R J., Moore P K. The effect of 6-oxo-PGE, on human platelet aggregation in whole blood in vitro. J Pharm Pharmacol 1985; 37: 139–141
- Knofler R., Urano T, Malyszko J, Takada Y, Takada A. In vitro effects of endothelin-1 on collagen- and ADP-induced aggregation in human whole blood and platelet rich plasma. Thromb Res 1995; 77: 69–78
- Born G. V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
- Malyszko J, Urano T, Knofler R, et al. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 1994; 75: 569–576
- Niedelberger W, Schaub B P., Beveridge T. High performance liquid chromatographic determination of cyclosporin A in human plasma and serum. J Chromatogr 1980; 182: 454–458
- Reynolds D. J.M., Aronson J K. Cyclosporin. BMJ 1992; 305: 1491–1494
- Cohen H, Neild G H., Patel R. Mackie I J, Machin S J. Thromb Res 1988; 49: 91–101, Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporine-treated renal allograft recipients
- Frampton G, Parbtani A, Marchesi D, et al. In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. Kidney Int 1983; 23: 506–513
- Fishman S J., Wylonis L J., Glickman J D., et al. Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res 1991; 51: 93–98
- Cohen R A., Vanhoutte P M. Platelets, serotonin and endothelial cells. Serotonin and the Cardiovascular System, P. M. Vanhoutte. Academic Press, New York 1985; 105–112
- Rees B. G.W. Hypothesis supporting the primary role of increased platelet activity in atherosclerosis and coronary heart disease. Med Lab Sci 1987; 44: 267–271
- De Clerck F, Vanhoutte P M. 5-Hydroxytryptamine in Peripheral Reactions. Raven Press, New York 1982
- Ueda D, Suzuki K, Malyszko J, et al. Fibrinolysis and serotonin under cyclosporine A treatment in renal transplant recipients. Thromb Res 1994; 75: 97–103
- Ueda D, Suzuki K, Malyszko J, et al. Serotonergk measures in cyclosporine A treated rats. Thromb Res 1994; 76: 171–179
- Brown Z, Neild G H., Willoughby J J., Somia N V., Cameron S. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation 1986; 42: 150–153
- Neild G H., Reuben R., Hartley R B., Cameron J S. Glomerular thrombi in renal allografts associated with cyclosporine treatment. J Clin Pathol 1985; 38: 253–258
- Sommer B G., Innes J T., Whitehurst R M., Sharma H M., Fergusson R M. Cyclosporine-associated renal arteriolopathy resulting in loss of allograft function. Am J Surg 1985; 149: 756–760
- Stork J E., Rahman M A., Dunn M J. Eicosanoids in experimental and human renal disease. Am J Med 1986; 80(Suppl 1A)34–45
- Starzl T E., Todo S, Fung J, Demetris A J., Venkatamaran R., Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989, ii: 1000–1004
- McMaster P, Buist L. FK 506 in transplantation. Transplant Proc 1993; 25: 2684–2685
- Wallemacq P E., Reding R. FK 506 (Tacrolimus) a novel immunosuppressant in organ transplantation: clinical, biomedical and analytical aspects. Clin Chem 1993; 39: 2219–2229
- Pelekanou V, Trezise A E., Moore A L., Kay J E. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function. Transplant Proc 1991; 23: 3200–3201
- Fuster V, Steele P M., Chesebro J H. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 1985; 5: 175B–184B